Drug‐induced prolongation of the QT interval: why the regulatory concern?

This publication has 30 references indexed in Scilit:

• Evaluation of Drug-Induced QT Interval Prolongation
  Drug Safety, 2001
• Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy
  European Heart Journal, 1998
• Prolongation of the QT Interval and the Sudden Infant Death Syndrome
  New England Journal of Medicine, 1998
• Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors
  Hepatology, 1998
• Electrocardiograms, high-dose antipsychotic treatment and College guidelines
  Psychiatric Bulletin, 1996
• Use of terfenadine and contraindicated drugs
  Published by American Medical Association (AMA) ,1996
• Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs
  JAMA, 1993
• Clinical safety profile of sotalol in the treatment of arrhythmias
  The American Journal of Cardiology, 1993
• Torsade de pointes due to quinidine: Observations in 31 patients
  American Heart Journal, 1984
• QT interval prolongation as predictor of sudden death in patients with myocardial infarction.
  Circulation, 1978